This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone quarter ended 30 September 2026: sales down 36 percent, Rs 5.67 lakh loss
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone revenue from operations was Rs 70.58 lakh in the quarter ended 30 September 2026, down 36.2 percent from Rs 110.60 lakh a year earlier. Profit after tax was a Rs 5.67 lakh loss versus Rs 0.14 lakh profit. EBITDA margin fell from 8.8 to 6.3 percent. Borrowings were Rs 117.89 lakh and equity Rs 21.85 lakh. Standalone six-month operating cash flow was positive Rs 0.38 lakh. Comparative cash flow figures were regrouped or rearranged.
Weaker sales, a quarterly loss and slimmer margins may pressure the stock. Cash flow was positive, but borrowings over five times equity add risk.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹0.71 Cr | ₹0.00 Cr | turned positive |
| Operating profit | ₹0.02 Cr | −₹0.19 Cr | turned positive |
| Profit after tax | ₹0.02 Cr | −₹0.19 Cr | turned positive |
| EBITDA margin | 3.8% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.